These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 20219649)

  • 1. Mice knock out for the histone acetyltransferase p300/CREB binding protein-associated factor develop a resistance to amyloid toxicity.
    Duclot F; Meffre J; Jacquet C; Gongora C; Maurice T
    Neuroscience; 2010 May; 167(3):850-63. PubMed ID: 20219649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced susceptibility of S-100B transgenic mice to neuroinflammation and neuronal dysfunction induced by intracerebroventricular infusion of human beta-amyloid.
    Craft JM; Watterson DM; Marks A; Van Eldik LJ
    Glia; 2005 Aug; 51(3):209-16. PubMed ID: 15810011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of memantine on soluble Alphabeta(25-35)-induced changes in peptidergic and glial cells in Alzheimer's disease model rat brain regions.
    Arif M; Chikuma T; Ahmed MM; Nakazato M; Smith MA; Kato T
    Neuroscience; 2009 Dec; 164(3):1199-209. PubMed ID: 19733635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of working memory but not in anxiety or stress response in p300/CBP associated factor (PCAF) histone acetylase knockout mice bred on a C57BL/6 background.
    Duclot F; Jacquet C; Gongora C; Maurice T
    Neurosci Lett; 2010 May; 475(3):179-83. PubMed ID: 20371377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abeta(31-35) peptide induce apoptosis in PC 12 cells: contrast with Abeta(25-35) peptide and examination of underlying mechanisms.
    Misiti F; Sampaolese B; Pezzotti M; Marini S; Coletta M; Ceccarelli L; Giardina B; Clementi ME
    Neurochem Int; 2005 Jun; 46(7):575-83. PubMed ID: 15843052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered memory capacities and response to stress in p300/CBP-associated factor (PCAF) histone acetylase knockout mice.
    Maurice T; Duclot F; Meunier J; Naert G; Givalois L; Meffre J; Célérier A; Jacquet C; Copois V; Mechti N; Ozato K; Gongora C
    Neuropsychopharmacology; 2008 Jun; 33(7):1584-602. PubMed ID: 17805310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Messenger RNA and protein expression analysis of voltage-gated potassium channels in the brain of Abeta(25-35)-treated rats.
    Pan Y; Xu X; Tong X; Wang X
    J Neurosci Res; 2004 Jul; 77(1):94-9. PubMed ID: 15197742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.
    Yao J; Petanceska SS; Montine TJ; Holtzman DM; Schmidt SD; Parker CA; Callahan MJ; Lipinski WJ; Bisgaier CL; Turner BA; Nixon RA; Martins RN; Ouimet C; Smith JD; Davies P; Laska E; Ehrlich ME; Walker LC; Mathews PM; Gandy S
    J Neurochem; 2004 Aug; 90(4):1011-8. PubMed ID: 15287908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid-beta precursor protein mediates neuronal toxicity of amyloid beta through Go protein activation.
    Sola Vigo F; Kedikian G; Heredia L; Heredia F; Añel AD; Rosa AL; Lorenzo A
    Neurobiol Aging; 2009 Sep; 30(9):1379-92. PubMed ID: 18187234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
    Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA
    J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-amyloid (1-42)-induced learning and memory deficits in mice: involvement of oxidative burdens in the hippocampus and cerebral cortex.
    Jhoo JH; Kim HC; Nabeshima T; Yamada K; Shin EJ; Jhoo WK; Kim W; Kang KS; Jo SA; Woo JI
    Behav Brain Res; 2004 Dec; 155(2):185-96. PubMed ID: 15364477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of BDNF against beta-amyloid induced neurotoxicity in vitro and in vivo in rats.
    Arancibia S; Silhol M; Moulière F; Meffre J; Höllinger I; Maurice T; Tapia-Arancibia L
    Neurobiol Dis; 2008 Sep; 31(3):316-26. PubMed ID: 18585459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin regulates brain amyloid beta peptide Abeta42 through modulation of proteolytic degradation.
    Saito T; Iwata N; Tsubuki S; Takaki Y; Takano J; Huang SM; Suemoto T; Higuchi M; Saido TC
    Nat Med; 2005 Apr; 11(4):434-9. PubMed ID: 15778722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presenilin 1 regulates the processing of beta-amyloid precursor protein C-terminal fragments and the generation of amyloid beta-protein in endoplasmic reticulum and Golgi.
    Xia W; Zhang J; Ostaszewski BL; Kimberly WT; Seubert P; Koo EH; Shen J; Selkoe DJ
    Biochemistry; 1998 Nov; 37(47):16465-71. PubMed ID: 9843412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic deletion or antagonism of kinin B(1) and B(2) receptors improves cognitive deficits in a mouse model of Alzheimer's disease.
    Prediger RD; Medeiros R; Pandolfo P; Duarte FS; Passos GF; Pesquero JB; Campos MM; Calixto JB; Takahashi RN
    Neuroscience; 2008 Feb; 151(3):631-43. PubMed ID: 18191900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silibinin attenuates amyloid beta(25-35) peptide-induced memory impairments: implication of inducible nitric-oxide synthase and tumor necrosis factor-alpha in mice.
    Lu P; Mamiya T; Lu LL; Mouri A; Niwa M; Hiramatsu M; Zou LB; Nagai T; Ikejima T; Nabeshima T
    J Pharmacol Exp Ther; 2009 Oct; 331(1):319-26. PubMed ID: 19638571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities.
    Savonenko A; Xu GM; Melnikova T; Morton JL; Gonzales V; Wong MP; Price DL; Tang F; Markowska AL; Borchelt DR
    Neurobiol Dis; 2005 Apr; 18(3):602-17. PubMed ID: 15755686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of amyloid beta toxicity in Alzheimer's disease model Tg2576 by intraventricular antiamyloid beta antibody.
    Chauhan NB; Siegel GJ
    J Neurosci Res; 2002 Jul; 69(1):10-23. PubMed ID: 12111811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restraining tumor necrosis factor-alpha by thalidomide prevents the amyloid beta-induced impairment of recognition memory in mice.
    Alkam T; Nitta A; Mizoguchi H; Saito K; Seshima M; Itoh A; Yamada K; Nabeshima T
    Behav Brain Res; 2008 May; 189(1):100-6. PubMed ID: 18325608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAGE does not affect amyloid pathology in transgenic ArcAbeta mice.
    Vodopivec I; Galichet A; Knobloch M; Bierhaus A; Heizmann CW; Nitsch RM
    Neurodegener Dis; 2009; 6(5-6):270-80. PubMed ID: 20145420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.